nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluridine—SLC22A6—Methazolamide—glaucoma	0.182	0.556	CbGbCtD
Trifluridine—SLC22A6—Acetazolamide—glaucoma	0.145	0.444	CbGbCtD
Trifluridine—Superficial punctate keratopathy—Brimonidine—glaucoma	0.0676	0.111	CcSEcCtD
Trifluridine—Keratopathy—Latanoprost—glaucoma	0.0348	0.0573	CcSEcCtD
Trifluridine—Keratopathy—Apraclonidine—glaucoma	0.0279	0.0458	CcSEcCtD
Trifluridine—Corneal oedema—Latanoprost—glaucoma	0.0225	0.037	CcSEcCtD
Trifluridine—Keratopathy—Brinzolamide—glaucoma	0.0225	0.0369	CcSEcCtD
Trifluridine—Corneal oedema—Bimatoprost—glaucoma	0.0174	0.0287	CcSEcCtD
Trifluridine—Hyperaemia—Latanoprost—glaucoma	0.0156	0.0257	CcSEcCtD
Trifluridine—Corneal oedema—Brimonidine—glaucoma	0.0154	0.0254	CcSEcCtD
Trifluridine—Corneal oedema—Dorzolamide—glaucoma	0.0148	0.0242	CcSEcCtD
Trifluridine—Corneal oedema—Brinzolamide—glaucoma	0.0145	0.0238	CcSEcCtD
Trifluridine—Punctate keratitis—Bimatoprost—glaucoma	0.0145	0.0238	CcSEcCtD
Trifluridine—Punctate keratitis—Brimonidine—glaucoma	0.0128	0.0211	CcSEcCtD
Trifluridine—Stinging—Dipivefrin—glaucoma	0.0128	0.021	CcSEcCtD
Trifluridine—Hyperaemia—Apraclonidine—glaucoma	0.0125	0.0205	CcSEcCtD
Trifluridine—Punctate keratitis—Dorzolamide—glaucoma	0.0122	0.0201	CcSEcCtD
Trifluridine—Punctate keratitis—Travoprost—glaucoma	0.0122	0.02	CcSEcCtD
Trifluridine—Punctate keratitis—Brinzolamide—glaucoma	0.012	0.0198	CcSEcCtD
Trifluridine—Hyperaemia—Brimonidine—glaucoma	0.0107	0.0176	CcSEcCtD
Trifluridine—Stinging—Echothiophate—glaucoma	0.0107	0.0176	CcSEcCtD
Trifluridine—Hyperaemia—Travoprost—glaucoma	0.0102	0.0168	CcSEcCtD
Trifluridine—Hyperaemia—Brinzolamide—glaucoma	0.0101	0.0165	CcSEcCtD
Trifluridine—Eyelid oedema—Latanoprost—glaucoma	0.00934	0.0154	CcSEcCtD
Trifluridine—Punctate keratitis—Betaxolol—glaucoma	0.00804	0.0132	CcSEcCtD
Trifluridine—Eyelid oedema—Apraclonidine—glaucoma	0.00747	0.0123	CcSEcCtD
Trifluridine—Intraocular pressure increased—Brimonidine—glaucoma	0.00736	0.0121	CcSEcCtD
Trifluridine—Eyelid oedema—Bimatoprost—glaucoma	0.00724	0.0119	CcSEcCtD
Trifluridine—Intraocular pressure increased—Brinzolamide—glaucoma	0.00691	0.0114	CcSEcCtD
Trifluridine—Punctate keratitis—Timolol—glaucoma	0.00657	0.0108	CcSEcCtD
Trifluridine—Eyelid oedema—Brimonidine—glaucoma	0.00641	0.0105	CcSEcCtD
Trifluridine—Stinging—Carbachol—glaucoma	0.00637	0.0105	CcSEcCtD
Trifluridine—Stinging—Levobunolol—glaucoma	0.00628	0.0103	CcSEcCtD
Trifluridine—Eyelid oedema—Dorzolamide—glaucoma	0.00612	0.0101	CcSEcCtD
Trifluridine—Eyelid oedema—Travoprost—glaucoma	0.0061	0.01	CcSEcCtD
Trifluridine—Eyelid oedema—Brinzolamide—glaucoma	0.00602	0.0099	CcSEcCtD
Trifluridine—Stinging—Latanoprost—glaucoma	0.00582	0.00957	CcSEcCtD
Trifluridine—Hyperaemia—Timolol—glaucoma	0.00549	0.00903	CcSEcCtD
Trifluridine—Stinging—Bimatoprost—glaucoma	0.00451	0.00742	CcSEcCtD
Trifluridine—Dry eye—Latanoprost—glaucoma	0.00436	0.00716	CcSEcCtD
Trifluridine—Stinging—Brimonidine—glaucoma	0.00399	0.00657	CcSEcCtD
Trifluridine—TK1—Nucleotide metabolism—TXN—glaucoma	0.0039	0.0599	CbGpPWpGaD
Trifluridine—Stinging—Dorzolamide—glaucoma	0.00382	0.00627	CcSEcCtD
Trifluridine—Stinging—Pilocarpine—glaucoma	0.00361	0.00593	CcSEcCtD
Trifluridine—Vision blurred—Echothiophate—glaucoma	0.00357	0.00587	CcSEcCtD
Trifluridine—Dry eye—Apraclonidine—glaucoma	0.00348	0.00572	CcSEcCtD
Trifluridine—TK1—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00339	0.0521	CbGpPWpGaD
Trifluridine—Dry eye—Bimatoprost—glaucoma	0.00338	0.00555	CcSEcCtD
Trifluridine—Eyelid oedema—Timolol—glaucoma	0.00329	0.0054	CcSEcCtD
Trifluridine—Pain—Dipivefrin—glaucoma	0.00315	0.00518	CcSEcCtD
Trifluridine—Dry eye—Brimonidine—glaucoma	0.00299	0.00491	CcSEcCtD
Trifluridine—Dry eye—Dorzolamide—glaucoma	0.00285	0.00469	CcSEcCtD
Trifluridine—Dry eye—Travoprost—glaucoma	0.00284	0.00467	CcSEcCtD
Trifluridine—Dry eye—Brinzolamide—glaucoma	0.00281	0.00461	CcSEcCtD
Trifluridine—TYMS—Circadian rythm related genes—ATOH7—glaucoma	0.00272	0.0418	CbGpPWpGaD
Trifluridine—Hypersensitivity—Dipivefrin—glaucoma	0.00272	0.00447	CcSEcCtD
Trifluridine—TYMP—Nucleotide metabolism—TXN—glaucoma	0.0027	0.0415	CbGpPWpGaD
Trifluridine—Dry eye—Pilocarpine—glaucoma	0.0027	0.00443	CcSEcCtD
Trifluridine—Pain—Echothiophate—glaucoma	0.00264	0.00434	CcSEcCtD
Trifluridine—Nausea—Physostigmine—glaucoma	0.00258	0.00423	CcSEcCtD
Trifluridine—Vision blurred—Metipranolol—glaucoma	0.00239	0.00393	CcSEcCtD
Trifluridine—TYMP—Bladder Cancer—MMP1—glaucoma	0.00238	0.0365	CbGpPWpGaD
Trifluridine—TYMP—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00235	0.0361	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—CCND2—glaucoma	0.00224	0.0345	CbGpPWpGaD
Trifluridine—Vision blurred—Carteolol—glaucoma	0.00222	0.00364	CcSEcCtD
Trifluridine—Dry eye—Clonidine—glaucoma	0.00215	0.00354	CcSEcCtD
Trifluridine—Stinging—Timolol—glaucoma	0.00205	0.00337	CcSEcCtD
Trifluridine—Vision blurred—Latanoprost—glaucoma	0.00194	0.00319	CcSEcCtD
Trifluridine—Dry eye—Betaxolol—glaucoma	0.00188	0.00308	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00183	0.0281	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—CDKN2A—glaucoma	0.00168	0.0259	CbGpPWpGaD
Trifluridine—Pain—Carbachol—glaucoma	0.00158	0.00259	CcSEcCtD
Trifluridine—Vision blurred—Apraclonidine—glaucoma	0.00155	0.00255	CcSEcCtD
Trifluridine—Pain—Levobunolol—glaucoma	0.00155	0.00255	CcSEcCtD
Trifluridine—Dry eye—Timolol—glaucoma	0.00153	0.00252	CcSEcCtD
Trifluridine—Hypersensitivity—Metipranolol—glaucoma	0.00153	0.00251	CcSEcCtD
Trifluridine—Vision blurred—Bimatoprost—glaucoma	0.00151	0.00248	CcSEcCtD
Trifluridine—Pain—Latanoprost—glaucoma	0.00144	0.00237	CcSEcCtD
Trifluridine—Hypersensitivity—Carteolol—glaucoma	0.00141	0.00233	CcSEcCtD
Trifluridine—TYMS—Nucleotide metabolism—TXN—glaucoma	0.00138	0.0213	CbGpPWpGaD
Trifluridine—TYMS—One Carbon Metabolism—MTHFR—glaucoma	0.00137	0.0211	CbGpPWpGaD
Trifluridine—Hypersensitivity—Levobunolol—glaucoma	0.00134	0.0022	CcSEcCtD
Trifluridine—Vision blurred—Brimonidine—glaucoma	0.00133	0.00219	CcSEcCtD
Trifluridine—TK1—Fluoropyrimidine Activity—TP53—glaucoma	0.00129	0.0198	CbGpPWpGaD
Trifluridine—Vision blurred—Dorzolamide—glaucoma	0.00127	0.00209	CcSEcCtD
Trifluridine—Vision blurred—Travoprost—glaucoma	0.00127	0.00208	CcSEcCtD
Trifluridine—Vision blurred—Brinzolamide—glaucoma	0.00125	0.00206	CcSEcCtD
Trifluridine—TYMP—Bladder Cancer—VEGFA—glaucoma	0.00124	0.0191	CbGpPWpGaD
Trifluridine—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—glaucoma	0.00123	0.0189	CbGpPWpGaD
Trifluridine—Nausea—Metipranolol—glaucoma	0.00123	0.00202	CcSEcCtD
Trifluridine—TK1—E2F transcription factor network—CDKN2A—glaucoma	0.00122	0.0188	CbGpPWpGaD
Trifluridine—Vision blurred—Pilocarpine—glaucoma	0.0012	0.00198	CcSEcCtD
Trifluridine—TYMS—Fluoropyrimidine Activity—MTHFR—glaucoma	0.0012	0.0185	CbGpPWpGaD
Trifluridine—Pain—Apraclonidine—glaucoma	0.00115	0.00189	CcSEcCtD
Trifluridine—Nausea—Carteolol—glaucoma	0.00114	0.00187	CcSEcCtD
Trifluridine—TK1—Metabolism—NARFL—glaucoma	0.00113	0.0173	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CA5A—glaucoma	0.00113	0.0173	CbGpPWpGaD
Trifluridine—Nausea—Diclofenamide—glaucoma	0.00112	0.00184	CcSEcCtD
Trifluridine—Pain—Bimatoprost—glaucoma	0.00112	0.00183	CcSEcCtD
Trifluridine—Nausea—Carbachol—glaucoma	0.00109	0.0018	CcSEcCtD
Trifluridine—TK1—E2F transcription factor network—CDKN1B—glaucoma	0.00108	0.0167	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—OPN4—glaucoma	0.00108	0.0166	CbGpPWpGaD
Trifluridine—Nausea—Levobunolol—glaucoma	0.00108	0.00177	CcSEcCtD
Trifluridine—Nausea—Methazolamide—glaucoma	0.00103	0.0017	CcSEcCtD
Trifluridine—Hypersensitivity—Apraclonidine—glaucoma	0.000991	0.00163	CcSEcCtD
Trifluridine—Pain—Brimonidine—glaucoma	0.000987	0.00162	CcSEcCtD
Trifluridine—Vision blurred—Clonidine—glaucoma	0.000961	0.00158	CcSEcCtD
Trifluridine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000958	0.0147	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—MMP9—glaucoma	0.000943	0.0145	CbGpPWpGaD
Trifluridine—Pain—Dorzolamide—glaucoma	0.000943	0.00155	CcSEcCtD
Trifluridine—Pain—Travoprost—glaucoma	0.000939	0.00154	CcSEcCtD
Trifluridine—TYMP—Bladder Cancer—TP53—glaucoma	0.000937	0.0144	CbGpPWpGaD
Trifluridine—Pain—Brinzolamide—glaucoma	0.000927	0.00152	CcSEcCtD
Trifluridine—TYMP—Fluoropyrimidine Activity—TP53—glaucoma	0.000892	0.0137	CbGpPWpGaD
Trifluridine—Pain—Pilocarpine—glaucoma	0.000891	0.00146	CcSEcCtD
Trifluridine—Hypersensitivity—Brimonidine—glaucoma	0.000851	0.0014	CcSEcCtD
Trifluridine—Vision blurred—Betaxolol—glaucoma	0.000837	0.00138	CcSEcCtD
Trifluridine—Hypersensitivity—Dorzolamide—glaucoma	0.000812	0.00134	CcSEcCtD
Trifluridine—Hypersensitivity—Travoprost—glaucoma	0.000809	0.00133	CcSEcCtD
Trifluridine—Nausea—Apraclonidine—glaucoma	0.000799	0.00131	CcSEcCtD
Trifluridine—Hypersensitivity—Brinzolamide—glaucoma	0.000799	0.00131	CcSEcCtD
Trifluridine—TYMP—Metabolism—CA5A—glaucoma	0.00078	0.012	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—NARFL—glaucoma	0.00078	0.012	CbGpPWpGaD
Trifluridine—Nausea—Bimatoprost—glaucoma	0.000775	0.00127	CcSEcCtD
Trifluridine—Hypersensitivity—Pilocarpine—glaucoma	0.000768	0.00126	CcSEcCtD
Trifluridine—Nausea—Acetazolamide—glaucoma	0.000715	0.00117	CcSEcCtD
Trifluridine—Pain—Clonidine—glaucoma	0.000712	0.00117	CcSEcCtD
Trifluridine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000702	0.0108	CbGpPWpGaD
Trifluridine—Nausea—Brimonidine—glaucoma	0.000686	0.00113	CcSEcCtD
Trifluridine—Vision blurred—Timolol—glaucoma	0.000683	0.00112	CcSEcCtD
Trifluridine—Nausea—Dorzolamide—glaucoma	0.000655	0.00108	CcSEcCtD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000653	0.01	CbGpPWpGaD
Trifluridine—Nausea—Travoprost—glaucoma	0.000652	0.00107	CcSEcCtD
Trifluridine—Nausea—Brinzolamide—glaucoma	0.000644	0.00106	CcSEcCtD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—TP53—glaucoma	0.00064	0.00983	CbGpPWpGaD
Trifluridine—Pain—Betaxolol—glaucoma	0.00062	0.00102	CcSEcCtD
Trifluridine—Nausea—Pilocarpine—glaucoma	0.000619	0.00102	CcSEcCtD
Trifluridine—Hypersensitivity—Clonidine—glaucoma	0.000613	0.00101	CcSEcCtD
Trifluridine—TK1—Metabolism—CA1—glaucoma	0.00055	0.00845	CbGpPWpGaD
Trifluridine—Hypersensitivity—Betaxolol—glaucoma	0.000534	0.000877	CcSEcCtD
Trifluridine—TK1—Metabolism—CTSA—glaucoma	0.000533	0.00818	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CCND2—glaucoma	0.000518	0.00796	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000512	0.00787	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000508	0.0078	CbGpPWpGaD
Trifluridine—Pain—Timolol—glaucoma	0.000506	0.000832	CcSEcCtD
Trifluridine—TK1—Metabolism—CA2—glaucoma	0.000503	0.00773	CbGpPWpGaD
Trifluridine—Nausea—Clonidine—glaucoma	0.000494	0.000813	CcSEcCtD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—PEX19—glaucoma	0.000491	0.00755	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000477	0.00733	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000464	0.00714	CbGpPWpGaD
Trifluridine—TYMS—Fluoropyrimidine Activity—TP53—glaucoma	0.000456	0.00701	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—FGFR1OP—glaucoma	0.000454	0.00697	CbGpPWpGaD
Trifluridine—Hypersensitivity—Timolol—glaucoma	0.000436	0.000717	CcSEcCtD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000436	0.00669	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—CDKN2A—glaucoma	0.000434	0.00667	CbGpPWpGaD
Trifluridine—Nausea—Betaxolol—glaucoma	0.00043	0.000707	CcSEcCtD
Trifluridine—TYMS—Cell Cycle—RAB8A—glaucoma	0.000427	0.00656	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—OPTN—glaucoma	0.000414	0.00636	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CA5A—glaucoma	0.000399	0.00614	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—NARFL—glaucoma	0.000399	0.00614	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—NGFR—glaucoma	0.000386	0.00593	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—CDKN1B—glaucoma	0.000385	0.00591	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000382	0.00587	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CA1—glaucoma	0.000381	0.00586	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—OPTN—glaucoma	0.00037	0.00569	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CTSA—glaucoma	0.000369	0.00567	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—NTRK1—glaucoma	0.000366	0.00563	CbGpPWpGaD
Trifluridine—TK1—Metabolism—TXN—glaucoma	0.000354	0.00545	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000352	0.00541	CbGpPWpGaD
Trifluridine—Nausea—Timolol—glaucoma	0.000352	0.000578	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.00035	0.00537	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CA2—glaucoma	0.000349	0.00536	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000334	0.00514	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000332	0.0051	CbGpPWpGaD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000319	0.0049	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000299	0.0046	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—FAS—glaucoma	0.000287	0.00441	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—CDKN1B—glaucoma	0.000279	0.00429	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GSTT1—glaucoma	0.000275	0.00422	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000266	0.00408	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000256	0.00393	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—TXN—glaucoma	0.000246	0.00377	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000235	0.00361	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000221	0.0034	CbGpPWpGaD
Trifluridine—TK1—Metabolism—ABCA1—glaucoma	0.000219	0.00336	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CYP1B1—glaucoma	0.000219	0.00336	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.00021	0.00323	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CA1—glaucoma	0.000195	0.003	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—GSTT1—glaucoma	0.00019	0.00293	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CCND2—glaucoma	0.00019	0.00292	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CTSA—glaucoma	0.000189	0.0029	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000188	0.00289	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CA2—glaucoma	0.000178	0.00274	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000178	0.00274	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GSTM1—glaucoma	0.000175	0.00269	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.00017	0.00262	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CCND2—glaucoma	0.00017	0.00261	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000162	0.00249	CbGpPWpGaD
Trifluridine—TK1—Metabolism—MTHFR—glaucoma	0.000155	0.00238	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDKN2B—glaucoma	0.000152	0.00234	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ABCA1—glaucoma	0.000152	0.00233	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP1B1—glaucoma	0.000152	0.00233	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000148	0.00228	CbGpPWpGaD
Trifluridine—TK1—Metabolism—APOE—glaucoma	0.000144	0.00221	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CAV1—glaucoma	0.000143	0.00219	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000127	0.00195	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—TXN—glaucoma	0.000126	0.00193	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—GSTM1—glaucoma	0.000121	0.00186	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000112	0.00172	CbGpPWpGaD
Trifluridine—TK1—Metabolism—NOS3—glaucoma	0.000108	0.00166	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—TP53—glaucoma	0.000107	0.00165	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—MTHFR—glaucoma	0.000107	0.00165	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—APOE—glaucoma	9.98e-05	0.00153	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CAV1—glaucoma	9.89e-05	0.00152	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PTGS2—glaucoma	9.87e-05	0.00152	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GSTT1—glaucoma	9.74e-05	0.0015	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDKN2A—glaucoma	9.74e-05	0.0015	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDKN2A—glaucoma	8.71e-05	0.00134	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDKN1B—glaucoma	8.63e-05	0.00133	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ABCA1—glaucoma	7.76e-05	0.00119	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP1B1—glaucoma	7.76e-05	0.00119	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDKN1B—glaucoma	7.71e-05	0.00119	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—NOS3—glaucoma	7.48e-05	0.00115	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PTGS2—glaucoma	6.84e-05	0.00105	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GSTM1—glaucoma	6.21e-05	0.000954	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—MTHFR—glaucoma	5.48e-05	0.000843	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—APOE—glaucoma	5.11e-05	0.000785	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CAV1—glaucoma	5.06e-05	0.000777	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—TP53—glaucoma	4.85e-05	0.000745	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—NOS3—glaucoma	3.83e-05	0.000588	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PTGS2—glaucoma	3.5e-05	0.000538	CbGpPWpGaD
